Bluejay Diagnostics (BJDX) Revenue (2022)
Bluejay Diagnostics' (BJDX) quarterly Revenue came in at $249040.0 in Q2 2022.
Analysis
Bluejay Diagnostics (BJDX) Revenue (2022) Analysis & Trends
Bluejay Diagnostics has disclosed Revenue across 1 years of filings, most recently posting $249040.0 for Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 30.07 Bn | 27.96 Bn | 2.18 Bn | 5.30 Bn |
| 2 | Lantheus Holdings | 6.57 Bn | 5.98 Bn | 241.86 Mn | 388.18 Mn |
| 3 | Heartflow | 4.12 Bn | 3.74 Bn | 53.19 Mn | 64.08 Mn |
| 4 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 225.30 Mn |
| 5 | Butterfly Network | 1.99 Bn | 1.87 Bn | 23.29 Mn | 32.61 Mn |
| 6 | Ceribell | 927.98 Mn | 798.72 Mn | 25.94 Mn | 28.10 Mn |
| 7 | QuidelOrtho | 883.12 Mn | 759.72 Mn | - | - |
| 8 | Varex Imaging | 778.85 Mn | 679.65 Mn | 76.70 Mn | 210.50 Mn |
| 9 | Prenetics Global | 338.80 Mn | 279.75 Mn | 30.20 Mn | 46.49 Mn |
| 10 | Bluejay Diagnostics | 2.08 Mn | 2.08 Mn | - | - |